What Researchers Did
Researchers reviewed existing studies on potential treatments for protecting the brains of newborns affected by hypoxic-ischaemic encephalopathy (HIE), a brain injury caused by lack of oxygen.
What They Found
They found that xenon and therapeutic hypothermia are two highly promising neuroprotective agents for treating HIE in newborns. The therapeutic benefits of both xenon and hypothermia have been confirmed in several laboratory and animal studies, both when used individually and in combination. These findings suggest that it may be only a matter of time before these agents become standard care for neonates with HIE.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a review article, this study synthesizes existing research rather than presenting new clinical trial data or specific patient outcomes.